is there still a glp-1 shortage 📢 FDA has determined the of semaglutide injection products, glucagon-like peptide 1 (GLP-1) medication, resolved. Patients and prescribers may see intermittent and limited localized supply disruptions as the Ozempic and Wegovy officially moved

NGF steers microglia toward a neuroprotective phenotype

The Best Subcutaneous Injection Sites for Peptides Subcutaneous tissue, the layer of fat just beneath the skin, is the target for peptide injection

CrossRef Immune Determinants of MASLD Progression: From Immunometabolic Reprogramming to Fibrotic Transformation Senping Xu, Zhaoshan Zhang, Zhongquan Zhou, Jiawei Guo Biology.2026

The Science Behind GHK-Cu and Skin Tightening The skin-tightening effects of GHK-Cu stem from its documented ability to stimulate production of the structural proteins that maintain skin firmness while simultaneously inhibiting their breakdown

Akisu M, Kultursay N, Coker I, Huseyinov A